Recently I’ve been thinking about how our field is evolving, especially with the rise of remote trials and digital tools. I switched to a hybrid model last year, and it’s made me rethink my approach to study design and patient engagement. I’d love to hear how others are adapting and what changes they foresee in the next few years.